Company profile for Laevoroc Oncology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our mission is to leverage world-class technologies, our oncology expertise and extensive R&D and commercial experience to approach innovation in cancer therapeutics in a way that combines the pragmatic with the visionary. Our home is in Zug, Switzerland, our minds are on the art of oncology drug development, and our hearts are with patients living with cancer.At Laevoroc, our mission is to leverage word-class technologies, o...
Our mission is to leverage world-class technologies, our oncology expertise and extensive R&D and commercial experience to approach innovation in cancer therapeutics in a way that combines the pragmatic with the visionary. Our home is in Zug, Switzerland, our minds are on the art of oncology drug development, and our hearts are with patients living with cancer.At Laevoroc, our mission is to leverage word-class technologies, our oncology expertise and extensive R&D and commercial experience to approach innovation in cancer therapeutics in a way that combines the pragmatic with the visionary.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Boesch, 37, Hünenberg, Zug 6331
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/02/28/2616693/0/en/Laevoroc-Immunology-Announces-FDA-Orphan-Drug-Designation-Granted-to-LR-09-a-Novel-Metabolic-Immune-Checkpoint-Inhibitor-for-the-Treatment-of-Leukemia-Relapse-after-Allogeneic-Stem.html

GLOBENEWSWIRE
28 Feb 2023

https://www.pharmatimes.com/news/laevoroc_announces_promising_purine_nucleoside_phosphorylase_data_1482785

PHARMATIMES
08 Dec 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty